SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
TREATMENT EFFECTS ON NEUROLOGIC OUTCOMES
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
RANDOMIZED CONTROLLED TRIAL OF MARAVIROC FOR HIV-ASSOCIATED NEUROCOGNITIVE IMPAIRMENT (ABSTRACT
333)
Cecilia M Shikuma
University of Hawaii, Honolulu, HI, USA
IMPACT OF SWITCH FROM EFV/F/TDF TO B/F/TAF ON PSYCHIATRIC SYMPTOMS AND NEUROCOGNITION (ABSTRACT
334)
Alessandra Vergori
Lazzaro Spallanzani Hospital, Rome, Italy
THE USE OF LESS NEUROTOXIC ANTIRETROVIRALS: SECONDARY ENDPOINTS OF THE MARAND-X STUDY (ABSTRACT
335)
Andrea Calcagno
University of Turin, Torino, Italy
PEMBROLIZUMAB FOR PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) IN PLWH (ABSTRACT
336)
Carmela Pinnetti
Lazzaro Spallanzani Hospital, Rome, Italy
INTRANASAL INSULIN IMPROVES ATTENTION AND MEMORY IN PEOPLE WITH HIV (ABSTRACT
337)
Anne D Yacoub
Johns Hopkins School of Medicine, Baltimore, MD, USA
STATIN USE AND COGNITIVE PERFORMANCE IN THE MULTICENTER AIDS COHORT STUDY (ABSTRACT
338)
Samantha A Molsberry
Harvard T.H. Chan School of Public Health, Boston, MA, USA
REVERSIBILITY OF SLEEP DISTURBANCES AFTER SWITCHING FROM DTG/3TC/ABC TO DRV/C/FTC/TAF (ABSTRACT
339)
Ignacio Perez-Valero
Hospital Universitario La Paz, Madrid, Spain
STABLE IMPROVEMENT IN DEPRESSION 6 YEARS AFTER ART INITIATION DURING ACUTE HIV (ABSTRACT
340)
Phillip Chan
SEARCH, Institute of HIV Research and Innovation, Bangkok, Thailand
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|